abmart-banner
Global R&D Pipeline
My Favorite
Hot Targets:
5-HT2A receptor
Back
Total number of drugs
384
Phase II and later clinical stages
21.9%
Involving companies
391
Main therapeutic areas
Nervous System Diseases
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
DrugDrug Name EnDrug TypeTreatment FieldMechanism of ActionOriginatorDeveloperIndicationHighest Development StageHighest Development Stage (China)Approved Countries/RegionsApproved TimeApproved Time (China)Special ReviewADC TypeADC LinkerADC PayloadADC DARDrug NameAntibody TypeADC Linking SiteOperation
ZotepineZotepineSmall molecule drugNervous System DiseasesSerotonin 2a (5-HT2a) receptor antagonists Dopamine D2 receptor antagonistsLTL Pharma Co., Ltd.Astellas Pharma, Inc.Yungjin Pharm. Co., Ltd.LTL Pharma Co., Ltd.SanofiApprovedJapan Austria Czechia Germany South Korea Slovakia Taiwan Province1981-12-07Zotepine
detail  >
AripiprazoleAripiprazoleSmall molecule drugNervous System Diseases Congenital Disorders Other DiseasesSerotonin 1a (5-HT1a) receptor agonists Serotonin 2a (5-HT2a) receptor antagonists Dopamine D2 receptor agonists Dopamine D3 receptor agonistsOtsuka Holdings Co., Ltd.Accord Healthcare SLOrimed Pharma, Inc.Otsuka Australia Pharmaceutical Pty Ltd.Otsuka Pharmaceutical Netherlands B.V.Sandoz GmbHZentiva ksOtsuka Pharmaceutical Co., Ltd.Xiamen LP Pharmaceutical Co., Ltd.Otsuka Holdings Co., Ltd.Korea Otsuka Pharmaceutical Co., Ltd.Lyndra Therapeutics, Inc.Odan Laboratories Ltd.Zhuhai Livzon Weiqiu Technology Co., Ltd.Chengdu Kanghong Pharmaceutical Group Co., Ltd.ApprovedApprovedUnited States China European Union Japan Canada Australia Iceland South Korea Liechtenstein Norway2002-11-152004-10-11United StatesAripiprazole
detail  >
Perospirone Hydrochloride HydratePerospirone Hydrochloride HydrateSmall molecule drugNervous System DiseasesSerotonin 2a (5-HT2a) receptor antagonists Dopamine D2 receptor antagonistsSumitomo Pharma Co., Ltd.Livzon Group Livzon Pharmaceutical FactorySumitomo Pharma Co., Ltd.ApprovedApprovedChina Japan2000-12-222008-04-22Perospirone Hydrochloride Hydrate
detail  >
Quetiapine FumarateQuetiapine FumarateSmall molecule drugNervous System Diseases Other DiseasesSerotonin 2a (5-HT2a) receptor antagonists Dopamine D2 receptor antagonistsAstraZeneca Pharmaceuticals Co. Ltd.AstraZeneca Pharmaceuticals Co. Ltd.Luye Pharma Group Ltd.Astellas Pharma, Inc.Acerta Pharma BVConsegna Pharma, Inc.CHEPLAPHARM Arzneimittel GmbHLTL Pharma Co., Ltd.Kyowa Pharmaceutical Industry Co., Ltd.ApprovedApprovedUnited States China Japan1997-09-262000-01-01ChinaQuetiapine Fumarate
detail  >
OlanzapineOlanzapineSmall molecule drugNervous System Diseases Other Diseases Congenital DisordersSerotonin 2a (5-HT2a) receptor antagonists Serotonin 2c (5-HT2c) receptor antagonists 5-hydroxytryptamine receptors, ionotropic (HTR3) antagonists Dopamine D2 receptor antagonistsEli Lilly & Co.Glenmark Arzneimittel GmbHKrka dd Novo MestoViatris Ltd. (New Zealand)Teva Pharmaceuticals Europe BVCHEPLAPHARM Arzneimittel GmbHGlenmark Pharmaceuticals s.r.o.Eli Lilly & Co.Teva Branded Pharmaceutical Products R&D LLCPharmacor Pty Ltd.PARAPHARM DEVELOPMENT LIMITEDApprovedApprovedUnited States China European Union Japan United Kingdom Australia Iceland Liechtenstein Norway1996-09-271998-01-01ChinaOlanzapine
detail  >
RisperidoneRisperidoneSmall molecule drugNervous System Diseases Other DiseasesSerotonin 2a (5-HT2a) receptor antagonists Dopamine D2 receptor antagonistsJohnson & JohnsonLaboratorios Farmaceúticos Rovi SAShandong Luye Pharmaceutical Co., Ltd.Teva Canada Ltd.Consegna Pharma, Inc.Myung in Pharm Co., Ltd.Janssen Pharmaceuticals, Inc.Qilu Pharmaceutical Co., Ltd.HLS Therapeutics, Inc.ApprovedApprovedUnited States China European Union Japan Canada Iceland South Korea Liechtenstein Norway1993-12-292021-01-12Risperidone
detail  >
Sarpogrelate HydrochlorideSarpogrelate HydrochlorideSmall molecule drugCardiovascular DiseasesSerotonin 2a (5-HT2a) receptor antagonistsTanabe Pharma Corp.Tanabe Pharma Corp.Phase 3ApprovedChina Japan1993-07-02Sarpogrelate Hydrochloride
detail  >
ClozapineClozapineSmall molecule drugNervous System Diseases Other DiseasesSerotonin 2a (5-HT2a) receptor antagonists Dopamine receptors antagonists Gamma-aminobutyric acid A receptor antagonistsHLS Therapeutics, Inc.United Heritage Life Insurance Co.HLS Therapeutics, Inc.Douglas Pharmaceuticals America Ltd.AA Pharma, Inc.Novartis Pharma KKViatris Pty Ltd.Jiangsu Yixing Qianjin Pharmacy FactoryApprovedApprovedUnited States China Japan Canada Australia1985-01-011985-01-01Clozapine
detail  >
BromperidolBromperidolSmall molecule drugNervous System DiseasesSerotonin 2a (5-HT2a) receptor antagonists Dopamine D2 receptor antagonists Dopamine D3 receptor antagonistsApproved1982-01-01Bromperidol
detail  >
ThioridazineThioridazineSmall molecule drugNeoplasms Digestive System Disorders Immune System Diseases Hemic and Lymphatic DiseasesSerotonin 2a (5-HT2a) receptor antagonists Dopamine D1 receptor antagonists Dopamine D2 receptor antagonists Voltage-gated potassium channel subunit Kv11.1 blockers Alpha-1a adrenergic receptor antagonists Alpha-1b adrenergic receptor antagonistsNovartis Pharma AGBeijing Sopuxingda Pharmaceutical Research Co., Ltd.Helmholtz Zentrum MünchenPhase 3Phase 3United States1978-10-18Thioridazine
detail  >
Total 384 data
1
2
3
4
5
6
...
38
39